Certara Launches DIDB® Concomitant Meds Navigator, Extending Leadership in Drug Interaction Science
Meet DIDB Concomitant Meds Navigator—an evidence-based tool to identify contraindicated or monitored co-medications and manage…
Certara2025 年 9 月 22 日
Certara Launches Libra™: AI-Powered Drug-Induced Liver Injury Prediction Tool
RADNOR, Pa. – 2025 年 9 月 17 日 – Certara, Inc. （纳斯达克股票代码：CERT), a global leader in…
Certara2025 年 9 月 17 日
FAQs on Developing EMA Policy 0070 Submissions
This blog answers audience questions posed during our RAPS webinar, How to Plan for a…
Certara2025 年 9 月 15 日
The Top 10 Things You Need to Know About ADNCA Datasets
Learn how ADNCA datasets can modernize non-compartmental analysis: enhanced compliance, automations, and faster PK data…
Certara2025 年 9 月 11 日
Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research
The article, "Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research," explores a…
Danielle Pillsbury2025 年 9 月 10 日
AI-driven drug discovery picks up as FDA pushes to reduce animal testing
AI is revolutionizing drug discovery and safety testing as drug developers adopt these technologies in…
Certara2025 年 9 月 9 日
Large Biotech Streamlines Investigator’s Brochures with Certara’s Project Management Expertise
Learn how Certara's project management team helped a large biotech streamline the development and updates…
Certara2025 年 9 月 5 日
